Matches in Nanopublications for { ?s ?p "[Treatment with carbamazepine and gabapentin of a patient with primary erythermalgia (erythromelalgia) identified to have a mutation in the SCN9A gene, encoding a voltage-gated sodium channel.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 11 of
11
with 100 items per page.
- NP614979.RAaZwUHYE-F9jZdwMQT5I_wViteET2CEKF_ZQr6IBGSdQ130_assertion description "[Treatment with carbamazepine and gabapentin of a patient with primary erythermalgia (erythromelalgia) identified to have a mutation in the SCN9A gene, encoding a voltage-gated sodium channel.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP614979.RAaZwUHYE-F9jZdwMQT5I_wViteET2CEKF_ZQr6IBGSdQ130_provenance.
- NP29076.RAHzXGf1zo-La91KdYZnPU6dD-HvmrBXDyiTRsgjxFomI130_assertion description "[Treatment with carbamazepine and gabapentin of a patient with primary erythermalgia (erythromelalgia) identified to have a mutation in the SCN9A gene, encoding a voltage-gated sodium channel.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP29076.RAHzXGf1zo-La91KdYZnPU6dD-HvmrBXDyiTRsgjxFomI130_provenance.
- NP29188.RAoPj_iAsw3rrj2Ym2tpWl3WBT_Ch34gC-36s-kRvgop0130_assertion description "[Treatment with carbamazepine and gabapentin of a patient with primary erythermalgia (erythromelalgia) identified to have a mutation in the SCN9A gene, encoding a voltage-gated sodium channel.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP29188.RAoPj_iAsw3rrj2Ym2tpWl3WBT_Ch34gC-36s-kRvgop0130_provenance.
- assertion description "[Treatment with carbamazepine and gabapentin of a patient with primary erythermalgia (erythromelalgia) identified to have a mutation in the SCN9A gene, encoding a voltage-gated sodium channel.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Treatment with carbamazepine and gabapentin of a patient with primary erythermalgia (erythromelalgia) identified to have a mutation in the SCN9A gene, encoding a voltage-gated sodium channel.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Treatment with carbamazepine and gabapentin of a patient with primary erythermalgia (erythromelalgia) identified to have a mutation in the SCN9A gene, encoding a voltage-gated sodium channel.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP746934.RAAmiyUcfHs25H1EJUK45lvjtZGRSzn1e258A5gy947yM130_assertion description "[Treatment with carbamazepine and gabapentin of a patient with primary erythermalgia (erythromelalgia) identified to have a mutation in the SCN9A gene, encoding a voltage-gated sodium channel.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP746934.RAAmiyUcfHs25H1EJUK45lvjtZGRSzn1e258A5gy947yM130_provenance.
- NP683403.RAm7Fj--yXqDfb-WQgLxoyd-5my3SGd4Sr0ILandpWJ_k130_assertion description "[Treatment with carbamazepine and gabapentin of a patient with primary erythermalgia (erythromelalgia) identified to have a mutation in the SCN9A gene, encoding a voltage-gated sodium channel.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP683403.RAm7Fj--yXqDfb-WQgLxoyd-5my3SGd4Sr0ILandpWJ_k130_provenance.
- NP24274.RAIGuiejGFXLONScy3ABYZZRPoF2V62r7GzGv3TsRICrI130_assertion description "[Treatment with carbamazepine and gabapentin of a patient with primary erythermalgia (erythromelalgia) identified to have a mutation in the SCN9A gene, encoding a voltage-gated sodium channel.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP24274.RAIGuiejGFXLONScy3ABYZZRPoF2V62r7GzGv3TsRICrI130_provenance.
- NP683414.RAL6ajwLdo0FRPHwRdTUKPCteHyvZm1-XPZ2fBKvpC71g130_assertion description "[Treatment with carbamazepine and gabapentin of a patient with primary erythermalgia (erythromelalgia) identified to have a mutation in the SCN9A gene, encoding a voltage-gated sodium channel.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP683414.RAL6ajwLdo0FRPHwRdTUKPCteHyvZm1-XPZ2fBKvpC71g130_provenance.
- NP746935.RAKbNbqXhVFwQGhZqT3of4j7xbb5aFlo8d-Uv8qXfoD5Y130_assertion description "[Treatment with carbamazepine and gabapentin of a patient with primary erythermalgia (erythromelalgia) identified to have a mutation in the SCN9A gene, encoding a voltage-gated sodium channel.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP746935.RAKbNbqXhVFwQGhZqT3of4j7xbb5aFlo8d-Uv8qXfoD5Y130_provenance.